Previous adjusted EBITDA guidance was $108.0M-113.0M. Raises FY25 Modern Orals sales view to $100.0-$110.0M from $80.0M-95.0M.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB:
- Avis Budget downgraded, Sprouts upgraded: Wall Street’s top analyst calls
- Turning Point Brands initiated with a Hold at Needham
- Turning Point Brands: Promising Growth in Nicotine Pouches and Diverse Revenue Streams, But Current Valuation Justifies Hold Rating
- FRE Nicotine Pouches partners with PBR for ‘Unleash The Beast’